Connecting international families with children's hospitals across China — advanced therapies for childhood leukemia, solid tumors, congenital heart disease and rare diseases, delivered with child-first care.
Specialist appointment within 3–5 working days — no waiting lists
Treatment costs at 30%–50% of US / Europe
Full journey support in English, Russian & Chinese
For children facing complex, rare or refractory conditions, China's National Children's Medical Centers offer frontier therapies, high-volume expert teams and genuinely child-first environments — guided by multidisciplinary boards (MDT).
01.
Frontier Therapies for Children
Pediatric CAR-T, haploidentical HSCT, proton therapy and gene therapies are approved or in advanced trials in China — some unavailable in the child's home country.
02.
High-Volume Expert Teams
China's top children's hospitals treat among the world's highest case volumes. Chief specialists care for hundreds of children annually — a density of experience few institutions can match.
03.
Family-Friendly Cost Advantage
At comparable technology levels, total costs are typically 30%–50% of US / Europe — with transparent packaged pricing and no hidden markups.
04.
Fast Track, No Waiting
Skip 6–12 month waiting lists at home. From medical record submission to specialist consultation in as fast as 3–5 working days, with prioritized admission.
CENTERS OF EXCELLENCE
Departments & Specialty Centers
From flagship hematology & oncology to neonatal intensive care — explore the specialty centers that international families visit most, modeled on China's children's hospital structure.
Targeting complex, refractory and rare childhood conditions — from dual-target CAR-T and haploidentical transplant to eye-preserving retinoblastoma care.
China runs the world's largest pediatric CAR-T clinical program — CD19/CD22 products achieve >90% complete remission in relapsed/refractory childhood B-ALL, at roughly one third of Western costs.
Haploidentical transplant protocols pioneered in China enable virtually every child to find a donor — curative for leukemia, thalassemia and immune deficiencies, with outcomes matching matched-sibling transplants.
Proton beam spares growing tissues — critical for children with brain tumors and sarcomas. Shanghai's proton & heavy-ion center operates dedicated pediatric protocols with anesthesia support for young children.
Superselective intra-arterial chemotherapy delivers drug directly to the eye — saving both life and sight. The Xinhua Hospital program reports >99% survival with ~80% eye preservation.
From nusinersen to base-editing trials for thalassemia, innovative rare disease therapies are increasingly accessible in China through national reimbursement and the Boao Lecheng pilot zone.
Neonatal arterial switch, single-ventricle staging and minimally invasive repair — China's top centers operate on newborns as small as 2 kg with >98% survival for complex defects.
The China Edge: Equipment · Technology · Pharmaceuticals
From world-first imaging systems to gene-editing breakthroughs for thalassemia, China's pediatric capability has become a new choice for families worldwide.
uEXPLORER Total-body PET-CT
The world's first total-body PET-CT by United Imaging — about 40x higher sensitivity with as little as 1/40 the tracer dose, a gentler scan for small bodies.
uMR Jupiter 5.0T MRI
The world's first whole-body ultra-high-field 5.0T MRI — sharper neuroimaging for brain tumors and epilepsy focus mapping, with child-friendly fast-scan protocols.
Proton + Carbon-ion Platform
Dual-modality particle therapy with dedicated pediatric anesthesia and immobilization teams — sub-millimeter targeting that spares growing tissue.
Hybrid OR & Robotic Surgery
da Vinci and domestic Toumai four-arm robots plus hybrid operating rooms enable precise, minimally invasive pediatric tumor and cardiac surgery.
HOW IT WORKS
Your Family's Journey in 4 Steps
STEP 1
Free Case Review
Share medical records securely. Our medical team and a senior specialist assess your child's case within 48 hours.
STEP 2
Plan & Transparent Quote
Receive a personalized treatment plan, hospital recommendation and itemized cost estimate — before you commit to anything.
STEP 3
Travel & Treatment
We arrange visas, flights, accommodation and interpreters. A dedicated coordinator accompanies your family in hospital.
STEP 4
Return Home & Follow-up
Remote follow-up with your treating team, bilingual reports for home physicians, and fast-track return visits if needed.
SUCCESS STORIES
Little Fighters, Big Victories
Real journeys of international families who found hope in China — shared with permission, anonymized to protect each child's privacy.
Medical fees are paid directly to the hospital's official account at official pricing. Below are reference comparisons for common pediatric treatments.
Treatment
Reference cost in China
US / Europe reference
Typical saving
Pediatric CAR-T cell therapy (CD19)
¥1.0M – 1.3M
$400K – 500K+
≈ 65%
Haploidentical HSCT (all-inclusive)
¥300K – 500K
$300K – 800K
≈ 80%
Proton therapy (full course)
¥278K – 350K
$80K – 150K
≈ 60%
Congenital heart surgery (arterial switch / TOF)
¥150K – 250K
$150K – 400K
≈ 85%
Retinoblastoma intra-arterial chemo (per cycle)
¥30K – 60K
$15K – 45K
≈ 70%
MDT consultation & second opinion
¥3,000 – 8,000
$3,000 – 10,000
≈ 90%
* Reference ranges based on standard clinical pathways; a formal quotation follows the hospital's assessment. Medical fees are paid directly to the hospital — we never handle them.
Straight answers about treatment in China — costs, hospitals, language support and how the free case review works.
How much does CAR-T therapy cost for a child in China?
At our partner children's centers, pediatric CAR-T cell therapy typically costs between US$45,000 and US$70,000, including cell manufacturing and hospitalization — a fraction of US or European prices. An exact quote is provided after a free case review of your child's records.
How do I request a free case review?
Fill in the case review form on this page with your child's diagnosis and a short medical summary. Our pediatric coordination team responds within 24 hours with recommended hospitals, specialists and an estimated treatment plan and cost.
Which children's hospitals do you work with?
We partner with National Children's Medical Centers and Grade-A tertiary children's hospitals, including Beijing Children's Hospital (Capital Medical University) and other pediatric centers across China.
Do you support families who don't speak Chinese?
Yes. Every family gets a dedicated coordinator, professional medical interpreters (English/Russian), translated medical records and 7-day WhatsApp support at +86 138 1783 1623 throughout the stay.
How long does treatment in China usually take?
It depends on the therapy: CAR-T usually takes 4–6 weeks (evaluation, infusion and monitoring), bone marrow transplant 1.5–3 months, and cardiac surgery about 2–4 weeks. We arrange medical visas, airport pickup and family accommodation.
Is my child's medical information kept private?
Absolutely. Case details are reviewed only by our medical coordination team and the partner physicians involved. Recovery stories published on this site are anonymized and shared with the family's written consent.
FREE CASE REVIEW
Request a Free Case Review
Share your child's diagnosis and records. A senior specialist will review the case and our coordination team will contact you within 24 hours — free, confidential, no obligation.
